معرفی
Ola Nilsson is a Professor of Medical Science specializing in Pediatrics at Örebro University. He is affiliated with the School of Medical Sciences and Department of Medical Sciences. As a pediatrician and pediatric endocrinologist, his research focuses on growth disorders, skeletal diseases, and genetic mechanisms underlying childhood growth abnormalities. He leads a research group investigating skeletal growth regulation, particularly in conditions like achondroplasia and X-linked hypophosphatemia (XLH).
Education & Career:
- PhD in Pediatric Science (Karolinska Institutet, 2002)
- Postdoctoral research at NIH (2003)
- Principal Investigator at Karolinska Institutet (2006)
- Associate Professor of Pediatrics at Karolinska (2011)
- Specialist in Pediatric Endocrinology at NIH (2014)
- Professor at Örebro University (2016)
Research Focus: Dr. Nilsson's work combines clinical, genetic, and experimental studies to identify genetic causes of growth disorders. His group developed methods to map genetic expression in growth plate cells, enabling insights into skeletal maturation mechanisms. Key areas include aggrecan mutations, FGF23-related disorders, and therapies like burosumab for XLH.
Grants & Awards: Recipient of awards from the Pediatric Endocrine Society and European Society of Pediatric Endocrinology. Active in international collaborations, including the XLH Registry.
Labs & Teams: Leads a research team focused on skeletal biology and endocrine disorders at Örebro University Hospital. Collaborates globally on clinical trials and genetic studies.
